Gail M. Farfel - Aug 23, 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role: Chief Executive Officer, Director
Signature: /s/ Max A. Milbury, Attorney-in-Fact for Gail M. Farfel
Stock symbol: PMN
Transactions as of: Aug 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/25/2023, 04:19 PM
Previous filing: Jun 23, 2023
Next filing: Sep 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMN	Common Shares	Award		+53.2K	+2659.6%		55.2K	Aug 23, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMN	Warrants to purchase Common Shares	Award		+53.2K			53.2K	Aug 23, 2023	Common Shares	53.2K	$1.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 53,192 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.

Content

On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 53,192 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.